Skip to main content
Top
Published in: Clinical Rheumatology 1/2011

01-01-2011 | Original Article

Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis

Authors: Björn Sundström, Solveig Wållberg-Jonsson, Gunnar Johansson

Published in: Clinical Rheumatology | Issue 1/2011

Login to get access

Abstract

The aims of this study were to investigate, firstly, the relationship between diet and disease activity and, secondly, the presence of gastrointestinal symptoms and their relationship to diet among patients with ankylosing spondylitis (AS) using a cross-sectional design. One hundred sixty-five individuals diagnosed with AS were invited to complete a self-administered postal questionnaire regarding demographic data, diet, medication, and gastrointestinal symptoms in addition to two established disease assessment questionnaires, i.e., the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI). No significant correlation between diet and disease activity was found. Overall, 27% of the patients reported aggravating gastrointestinal problems when consuming certain foodstuff(s). The 30% of patients who reported suffering from gastrointestinal pain had significantly greater disease activity and poorer functional status according to their BASDAI and BASFI scores (p < 0.01 and p = 0.01, respectively). Patients who reported gastrointestinal pain had a significantly higher consumption of vegetables (p < 0.01) and lower consumption of milk and soured milk (p = 0.04). No significant correlation was found between the use of non-steroidal anti-inflammatory drugs (NSAID) and gastrointestinal symptoms. In multiple regression models, BASDAI and the consumption of vegetables were independent and statistically significant predictors of gastrointestinal pain. To conclude, in a group of Swedish AS patients, no correlation between diet and disease activity could be detected. There were, however, correlations between diet and gastrointestinal pain. Gastrointestinal problems were also found to be prevalent in AS, independent of NSAID usage.
Literature
1.
go back to reference Mielants H, Veys EM, Cuvelier C, De Vos M (1996) Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillières Clin Rheumatol 10:147–164CrossRefPubMed Mielants H, Veys EM, Cuvelier C, De Vos M (1996) Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillières Clin Rheumatol 10:147–164CrossRefPubMed
5.
go back to reference Hascelik G, Oz B, Olmez N, Memis A, Yoruk G, Unsal B, Ekinci N (2008) Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis. Rheumatol Int 29:755–758. doi:10.1007/s00296-008-0766-6 CrossRefPubMed Hascelik G, Oz B, Olmez N, Memis A, Yoruk G, Unsal B, Ekinci N (2008) Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis. Rheumatol Int 29:755–758. doi:10.​1007/​s00296-008-0766-6 CrossRefPubMed
6.
go back to reference van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed
8.
go back to reference Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R (2002) Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr 5:487–496CrossRefPubMed Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R (2002) Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr 5:487–496CrossRefPubMed
9.
go back to reference Bergström L, Kylberg E, Hagman U, Eriksson H, Bruce Å (1991) The food composition data base system (KOST-systemet)—its use for nutrient values [in Swedish]. Vår Föda 43:439–447 Bergström L, Kylberg E, Hagman U, Eriksson H, Bruce Å (1991) The food composition data base system (KOST-systemet)—its use for nutrient values [in Swedish]. Vår Föda 43:439–447
10.
11.
go back to reference Waldner A, Cronstedt H, Stenstrom CH (1999) The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity. Scand J Rheumatol 28(Suppl 111):10–16CrossRef Waldner A, Cronstedt H, Stenstrom CH (1999) The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity. Scand J Rheumatol 28(Suppl 111):10–16CrossRef
12.
go back to reference Cronstedt H, Waldner A, Stenstrom CH (1999) The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity. Scand J Rheumatol 28(Suppl 111):1–9CrossRef Cronstedt H, Waldner A, Stenstrom CH (1999) The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity. Scand J Rheumatol 28(Suppl 111):1–9CrossRef
16.
go back to reference Meuwissen SGM, Dekker-Saeys BJ, Agenant D, Tytgat GNJ (1978) Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. Ann Rheum Dis 37:30–32. doi:10.1136/ard.37.1.30 CrossRefPubMed Meuwissen SGM, Dekker-Saeys BJ, Agenant D, Tytgat GNJ (1978) Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. Ann Rheum Dis 37:30–32. doi:10.​1136/​ard.​37.​1.​30 CrossRefPubMed
18.
go back to reference Ebringer A, Wilson C (2000) HLA molecules, bacteria and autoimmunity. J Med Microbiol 49:305–311PubMed Ebringer A, Wilson C (2000) HLA molecules, bacteria and autoimmunity. J Med Microbiol 49:305–311PubMed
20.
go back to reference Ong DK, Mitchell SB, Barrett JS et al (2010) Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 25:1366–1373CrossRefPubMed Ong DK, Mitchell SB, Barrett JS et al (2010) Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 25:1366–1373CrossRefPubMed
21.
go back to reference Muir JG, Rose R, Rosella O, Liels K, Barrett JS, Shepherd SJ, Gibson PR (2009) Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 57:554–565. doi:10.1021/jf802700e CrossRefPubMed Muir JG, Rose R, Rosella O, Liels K, Barrett JS, Shepherd SJ, Gibson PR (2009) Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 57:554–565. doi:10.​1021/​jf802700e CrossRefPubMed
22.
23.
go back to reference Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N et al (2005) Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease. Clin Gastroenterol Hepatol 3:122–132. doi:10.1016/S1542-3565(04)00663-9 CrossRefPubMed Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N et al (2005) Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease. Clin Gastroenterol Hepatol 3:122–132. doi:10.​1016/​S1542-3565(04)00663-9 CrossRefPubMed
24.
go back to reference Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J et al (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294:G208–G216. doi:10.1152/ajpgi.00398.2007 CrossRefPubMed Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J et al (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294:G208–G216. doi:10.​1152/​ajpgi.​00398.​2007 CrossRefPubMed
Metadata
Title
Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis
Authors
Björn Sundström
Solveig Wållberg-Jonsson
Gunnar Johansson
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1625-x

Other articles of this Issue 1/2011

Clinical Rheumatology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.